“VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis”, Mediterr J Hematol Infect Dis, vol. 9, no. 1, p. e2017011, Jan. 2017, doi: 10.4084/mjhid.2017.011.